| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...

Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...

Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year ...

bDivision of Gastroenterology, The McGill University Health Center, Montréal General Hospital, McGill University, Montréal, QC, Canada cDivision of Clinical Epidemiology, The McGill University Health ...

A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori ...

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases-diagnosed before age 50-display unique biological and ...

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...

The NHS warns: "The chance of getting serious side effects can be higher if you take omeprazole for a long time (a year or ...

What patients need to know about omeprazole side effects, as the latest NHS guidance summarised below explains 'red flag' ...